GlassScriptPhysician profile
Michael G Cotant
NPI 1326003633
$6,080.23
in general payments reported to CMS, 2019-2025
31 companies · $632 in 2025
The $632 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,457 · 2020: $143 · 2021: $985 · 2022: $589 · 2023: $880 · 2024: $1,393 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,570 · Food and Beverage: $1,336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,569.86 |
| Food and Beverage | $1,335.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $2,536.94 | 2022-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $618.61 | 2019-2021 | |
| Janssen Biotech, INC. | $426.69 | 2019-2024 | Balversa, Akeega, Erleada |
| Ferring Pharmaceuticals INC. | $406.03 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $295.12 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $293.68 | 2021-2023 | Prolaris |
| Boston Scientific Corporation | $174.08 | 2019-2021 | |
| Neotract INC. | $165.79 | 2019-2020 | |
| Pfizer INC. | $145.52 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.44 | 2019-2021 | |
| Axonics, INC. | $118.61 | 2024 | Bulkamid, Axonics |
| Amgen INC. | $115.56 | 2019-2022 | |
| Coloplast Corp | $103.78 | 2019-2024 | Speedicath |
| 180 Medical, INC. | $60.08 | 2019 | |
| Merck Sharp & Dohme LLC | $58.94 | 2020-2023 | Keytruda, Lynparza, Welireg |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $56.50 | 2021 | |
| Antares Pharma, INC. | $47.52 | 2019-2022 | |
| Procept Biorobotics Corporation | $47.24 | 2022 | |
| Convatec INC. | $40.82 | 2024 | |
| Blue Earth Diagnostics | $33.69 | 2019 | |
| Endo Pharmaceuticals INC. | $30.32 | 2019 | |
| Srs Medical Systems, INC. | $26.85 | 2023 | Urocuff |
| Janssen Pharmaceuticals, INC | $23.20 | 2019 | |
| Dendreon Pharmaceuticals LLC | $21.11 | 2019 | |
| Olympus America INC. | $19.68 | 2019 | |
| Zyla Life Sciences, INC. | $19.16 | 2019 | |
| Sumitomo Pharma America, INC. | $19.09 | 2023 | Orgovyx |
| Medtronic USA, INC. | $15.73 | 2020 | |
| Tersera Therapeutics LLC | $14.74 | 2022 | |
| Allergan, INC. | $12.70 | 2019 | |
| Cook Medical LLC | $12.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cotant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.